ducovest

RODM:ARCA-Hartford Multifactor Developed Markets (ex-US) (USD)

ETF | Foreign Large Blend | NYSE Arca

Last Closing

USD 28.06

Change

-0.21 (-0.73)%

Market Cap

USD 0.03B

Volume

0.05M
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

The investment seeks to provide investment results that, before fees and expenses, correspond to the total return performance of the Hartford Risk-Optimized Multifactor Developed Markets (ex-US) Index. The fund generally invests at least 80 percent of its assets in securities of the index and in depositary receipts representing securities of the index. The index is designed to address risks and opportunities within developed international economies outside the U.S. by selecting equity securities of companies domiciled within developed international equity markets exhibiting a favorable combination of factor characteristics.

Company Website : http://www.latticestrategies.com/

Currency: USD

Country : USA

Inception Date: 25/02/2015

Primary Benchmark: Hartford RiskOptimized DM ExUS TR USD

Primary Index: MSCI ACWI Ex USA NR USD

Gross Expense Ratio: 0.5%

Management Expense Ratio: 0.31 %

Unadjusted Closing Price

Adjusted Closing Price

Assets

N/A

Top Holdings

N/A

Symbol Company Name Allocation
IITSF Intesa Sanpaolo S.p.A 1.00 %
HSITF Hadasit Bio-Holdings Ltd 0.97 %
Top Sectors

N/A

Top Regions

N/A

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-06-26 )

Largest Industry Peers for Foreign Large Blend

Symbol Name Mer Price(Change) Market Cap
SCHF Schwab International Equity ET.. 0.06 %

N/A

 USD 41.50B
SPDW SPDR S&P World ex US 0.05 %

N/A

 USD 21.33B
IDEV iShares Core MSCI Internationa.. 0.03 %

N/A

 USD 14.84B
IQLT iShares MSCI Intl Quality Fact.. 0.30 %

N/A

 USD 8.36B
DBEF Xtrackers MSCI EAFE Hedged Equ.. 0.36 %

N/A

 USD 6.52B
INTF iShares Edge MSCI Multifactor .. 0.30 %

N/A

 USD 1.22B
QEFA SPDR® MSCI EAFE StrategicFact.. 0.30 %

N/A

 USD 1.00B
HFXI IQ 50 Percent Hedged FTSE Inte.. 0.20 %

N/A

 USD 0.81B
JHMD John Hancock Multifactor Devel.. 0.45 %

N/A

 USD 0.75B
MFDX PIMCO RAFI Dynamic Multi-Facto.. 0.40 %

N/A

 USD 0.29B

ETFs Containing RODM

N/A

Market Performance

  Market Performance vs. Industry/Classification (Foreign Large Blend) Market Performance vs. Exchange (NYSE Arca)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 2.33% 30% F 52% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 2.33% 20% F 43% F
Trailing 12 Months  
Capital Gain 7.63% 33% F 56% F
Dividend Return 2.09% 31% F 31% F
Total Return 9.73% 33% F 52% F
Trailing 5 Years  
Capital Gain -0.36% 17% F 45% F
Dividend Return 12.70% 39% F 51% F
Total Return 12.34% 17% F 42% F
Average Annual (5 Year Horizon)  
Capital Gain 1.29% 13% F 46% F
Dividend Return 4.31% 13% F 48% F
Total Return 3.02% 77% C+ 60% D-
Risk Return Profile  
Volatility (Standard Deviation) 15.76% 68% D+ 62% D
Risk Adjusted Return 27.37% 16% F 50% F
Market Capitalization 0.03B 67% D+ 57% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Underpriced compared to earnings

The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.